arrow
D

Donna R. Rivera

Kaiser Permanente
H指数:26
被引数:4,538

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data

评估晚期癌症总生存获益:外部对照队列研究结合真实世界数据的作用

2026-02-110
OAAI
Real-World Outcomes and Treatment Patterns in Patients With Acute Myeloid Leukemia and TP53 Gene Mutation or 17p Deletion

急性髓系白血病合并TP53基因突变或17p缺失患者的真实世界结局与治疗模式

2025-12-130
OAAI
Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer

年龄与Ⅰ期-ⅢA期乳腺癌女性化疗剂量减量的关联

2025-11-010
PRE
Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study
2025-02-010
PRE
A Unified Approach to Health Data Exchange: A Report From the US DHHS

健康数据交换的统一方法:美国卫生与公众服务部报告

2025-01-182
PRE
Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making

为监管和卫生技术评估 (HTA) 决策报告真实世界证据的加拿大指南的开发

2024-12-010
OAAI
Feasibility of structuring electronic health record data to facilitate real-world data research: ICAREdata methods applied to multicenter cancer clinical trials

构建电子健康记录数据以促进真实世界数据研究的可行性: ICAREdata方法应用于多中心癌症临床试验

CANCER
IF5.1
2024-08-282
OAAI
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system

在综合医疗保健提供系统中,在i-iiia期乳腺癌中使用NCCN指南化疗方案的前景

2024-08-160
PRE
Evaluation of Real-World Tumor Response Derived From Electronic Health Record Data Sources: A Feasibility Analysis in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Chemotherapy
2024-08-011
OAAI
Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer
2024-07-251
PRE
Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer
2024-07-060
PRE
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019
2024-06-131
OAAI
Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer
2024-04-014
PRE